Cargando…

Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by Step

Throughout the past years we stepwise modified our immunosuppressive treatment regimen for patients with antibody-mediated rejection (ABMR). Here, we describe three consecutive groups treated with different regimens. From 2005 until 2008, we treated all patients with biopsy-proven ABMR with rituxima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lachmann, Nils, Duerr, Michael, Schönemann, Constanze, Pruß, Axel, Budde, Klemens, Waiser, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306998/ https://www.ncbi.nlm.nih.gov/pubmed/28255562 http://dx.doi.org/10.1155/2017/6872046

Ejemplares similares

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016)

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
por: Eskandary, Farsad, et al.
Publicado: (2019)

The effect of histopathologic and clinical features on allograft survival in renal transplant patients with antibody-mediated rejection
por: Akagun, Tulin, et al.
Publicado: (2016)

Poor Long-Term Renal Allograft Survival in Patients with Chronic Antibody-Mediated Rejection, Irrespective of Treatment—A Single Center Retrospective Study
por: Wu, Kaiyin, et al.
Publicado: (2021)

Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody
por: Suneja, Manish, et al.
Publicado: (2012)

Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial
por: Mayer, Katharina A., et al.
Publicado: (2022)

MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection
por: Matz, Mareen, et al.
Publicado: (2018)

Not all inflammation in a renal allograft is rejection
por: Alquadan, Kawther F., et al.
Publicado: (2018)

Early Eosinophilic Antibody-mediated Rejection in a Renal Allograft Recipient
por: Satish, H., et al.
Publicado: (2018)

Immunophenotyping in BK Virus Allograft Nephropathy Distinct from Acute Rejection
por: Li, Xue, et al.
Publicado: (2013)

The Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection in Renal Transplant Recipients
por: An, Gun Hee, et al.
Publicado: (2014)

Impact of Acute Rejection on Kidney Allograft Outcomes in Recipients on Rapid Steroid Withdrawal
por: Heilman, R. L., et al.
Publicado: (2011)

THE ROLE OF HUMORAL ANTIBODY IN THE REJECTION OF PRIMARY RENAL ALLOGRAFTS IN SHEEP
por: Pedersen, Niels C., et al.
Publicado: (1974)

A Systematic Review and Meta-Analysis of Rituximab in Antibody-mediated Renal Allograft Rejection
por: Hychko, G., et al.
Publicado: (2011)

Donor plasma mitochondrial DNA is associated with antibody-mediated rejection in renal allograft recipients
por: Han, Fei, et al.
Publicado: (2021)

Association between epidermal growth factor (EGF) and EGF receptor gene polymorphisms and end-stage renal disease and acute renal allograft rejection in a Korean population
por: Kim, Byeong Woo, et al.
Publicado: (2020)

A bibliometric and knowledge-map analysis of antibody-mediated rejection in kidney transplantation
por: Zhang, Jinhua, et al.
Publicado: (2023)

Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure
por: Parajuli, Sandesh, et al.
Publicado: (2019)

Salvaging of severely ruptured living-related renal allograft secondary to acute antibody mediated rejection
por: Almarastani, Mohamad, et al.
Publicado: (2014)

B Cell Activating Factor, Renal Allograft Antibody-Mediated Rejection, and Long-Term Outcome
por: Xu, Haiyan, et al.
Publicado: (2018)

The therapeutic challenge of late antibody‐mediated kidney allograft rejection
por: Böhmig, Georg A., et al.
Publicado: (2019)

The genetic determinants of renal allograft rejection
por: Hernandez‐Fuentes, Maria, et al.
Publicado: (2018)

Educational Case: Renal allograft rejection
por: Dai, Harrison, et al.
Publicado: (2022)

Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism
por: Mühlbacher, Jakob, et al.
Publicado: (2021)

Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival
por: Trailin, Andriy V., et al.
Publicado: (2017)

Low CD4/CD8 Ratio in Bronchus-Associated Lymphoid Tissue Is Associated with Lung Allograft Rejection
por: Shenoy, K. V., et al.
Publicado: (2012)

Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts
por: Jordan, Stanley C., et al.
Publicado: (2022)

Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine
por: Kamel, Mahmoud, et al.
Publicado: (2016)

Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection
por: Li, Xin, et al.
Publicado: (2022)

Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes
por: Thomas, Merlin C, et al.
Publicado: (2000)

Antibody-Mediated Rejection of Arterialised Venous Allografts Is Inhibited by Immunosuppression in Rats
por: Splith, Katrin, et al.
Publicado: (2014)

Role of anti-vimentin antibodies in allograft rejection
por: Rose, Marlene L
Publicado: (2013)

Symptomatic lymphocele developing soon after acute renal allograft rejection: coincidental or causal connection?
por: Asim, Muhammad, et al.
Publicado: (2013)

Serum sickness following rabbit anti-thymocyte globulin for acute vascular renal allograft rejection
por: Teng, Jessie, et al.
Publicado: (2012)

Impact of acute kidney injury on renal allograft survival
por: Nagarajan, Mani, et al.
Publicado: (2016)

Renal allograft surveillance with allospecific T-cytotoxic memory cells
por: Rohan, Vinayak S., et al.
Publicado: (2020)

Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft Recipients
por: Mühlbacher, Jakob, et al.
Publicado: (2020)

Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells
por: Matsuda, Yoshiko, et al.
Publicado: (2021)

The negative impact of T cell–mediated rejection on renal allograft survival in the modern era
por: Rampersad, Christie, et al.
Publicado: (2021)

Patterns of Early Rejection in Renal Retransplantation: A Single-Center Experience
por: Zhu, Lan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_du7eipggeb4fl4570vtt58diom